KAMERON PRICE: Open Payments
NPI 1982368262 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 32 payments from 11 companies in 2025. Trend: 2023 $807 · 2024 $516 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
| Bausch Health US, LLC | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, Qelbree, TRINTELLIX, APLENZIN, Jornay PM.
Industry payments across SC — which companies pay providers there.
